carmustine has been researched along with thymidine in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (74.07) | 18.7374 |
| 1990's | 6 (22.22) | 18.2507 |
| 2000's | 1 (3.70) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, T; McMenamin, MG; Schein, PS | 1 |
| Bhuyan, BK; Day, KJ; Fraser, TJ | 1 |
| Barker, M; Deen, DF; Hoshino, T; Knebel, K; Nomura, K | 1 |
| Nakamura, T; Sawada, H; Tashima, M; Tatsumi, K; Uchino, H | 1 |
| Bains, E; Jett, J; Maruyama, Y; Raju, MR | 1 |
| Gola, A; Kuliczkowski, K; Sedek, K | 1 |
| August, EM; Cooper, DL; Prusoff, WH | 1 |
| Bizzari, JP; Deloffre, P; Etienne, MC; Fischel, JL; Formento, P; Frenay, M; Gioanni, J; Milano, G | 1 |
| August, EM; Prusoff, WH | 1 |
| Frome, E; Godfrey, G; Lindenschmidt, RC; Witschi, H | 1 |
| Carpenter, L; Hill, GJ; Hill, HZ; Lea, MA; Luke, A; Martinson, CF; Velazquez, O | 1 |
| Lin, TS; Prusoff, WH | 1 |
| D'Incalci, M; Erba, E; Landoni, F; Lorico, A; Mangioni, C; Morasca, L; Pepe, S; Ubezio, P | 1 |
| Kehrer, JP; Klein-Szanto, AJ | 1 |
| Bleehen, NM; Twentyman, PR | 1 |
| Lichter, W; Lopez, DM; Sigel, MM | 1 |
| Bostick, F; Rosenoff, SH; Young, RC | 1 |
| Alexander, JA; Wheeler, GP | 1 |
| Shapiro, WR | 1 |
| Horgan, CM; Tisdale, MJ | 1 |
| Kanter, PM; Schwartz, HS; West, CR | 1 |
| Durie, BG; Hofmann, V; Salmon, SE | 1 |
| Lin, HS | 1 |
| Hansson, J; Jungnelius, U; Mannervik, B; Ridderström, M; Ringborg, U | 1 |
| Cooper, DL; Durivage, HJ; Sandler, AB; Schultz, MZ | 1 |
| Guo, X; Haslund, B; Mozdziesz, DE; Poo, WJ | 1 |
| Noronha, AM; Wilds, CJ; Xu, F | 1 |
1 trial(s) available for carmustine and thymidine
| Article | Year |
|---|---|
A phase I pilot study of BCNU plus thymidine in patients with refractory cancer.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Carmustine; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Neoplasms; Pilot Projects; Thymidine | 1996 |
26 other study(ies) available for carmustine and thymidine
| Article | Year |
|---|---|
Chlorozotocin, 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose, an antitumor agent with modified bone marrow toxicity.
Topics: Animals; Antineoplastic Agents; Blood Cell Count; Bone Marrow; Carmustine; DNA, Neoplasm; Ethyl Chloride; Leukemia L1210; Leukocytes; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neutrophils; Streptozocin; Thymidine | 1975 |
Cell proliferation kinetics and drug sensitivity of exponential and stationary populations of cultured L1210 cells.
Topics: Amino Acids; Animals; Antineoplastic Agents; Carmustine; Cell Division; Cell Survival; Cells, Cultured; Culture Media; Cytarabine; Dactinomycin; Daunorubicin; DNA, Neoplasm; Doxorubicin; Glucose; Hydroxyurea; Kinetics; Leukemia L1210; Lomustine; Streptozocin; Thymidine; Vincristine | 1977 |
BCNU-induced perturbations in the cell cycle of 9L rat brain tumor cells.
Topics: Animals; Autoradiography; Brain Neoplasms; Carmustine; Cell Cycle; Cell Line; Cytological Techniques; Kinetics; Rats; Thymidine | 1978 |
Effect of 1,3-bis(2-chloroethyl)-1-nitrosourea on newly synthesized DNA in L-1210 cells.
Topics: Animals; Carmustine; Cells, Cultured; DNA Replication; DNA, Neoplasm; Kinetics; Leukemia L1210; Mice; Molecular Weight; Thymidine | 1979 |
Study of in vivo tumor state and response to therapy by analysis of DNA distribution.
Topics: Animals; Carmustine; Cell Survival; Cobalt Radioisotopes; DNA, Neoplasm; Female; Hydroxyurea; Kinetics; Lymphoma; Mechlorethamine; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Radioisotope Teletherapy; Thymidine | 1976 |
Myeloma cell resistance to melphalan, BCNU and epirubicin determined in vitro with the 3H-thymidine incorporation technique prior to chemotherapy.
Topics: Adult; Bone Marrow; Carmustine; Drug Resistance; Epirubicin; Humans; Immunoglobulins; Melphalan; Middle Aged; Multiple Myeloma; Thymidine; Tritium; Tumor Cells, Cultured | 1992 |
Inhibition of poly(adenosine diphosphate-ribose) polymerase by thymidine and thymidine analogues in L1210 cells and its relationship to the potentiation of the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea but not of 3'-[3-(2-chloroethyl)-3-n
Topics: Animals; Antineoplastic Agents; Carmustine; Dideoxynucleosides; DNA; DNA Damage; Drug Synergism; Enzyme Activation; Leukemia L1210; Mice; Poly(ADP-ribose) Polymerase Inhibitors; Thymidine | 1991 |
In vitro chemosensitivity testing of Fotemustine (S 10036), a new antitumor nitrosourea.
Topics: Antineoplastic Agents; Carmustine; Cell Division; Cisplatin; Dacarbazine; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Lomustine; Melanoma; Nitrosourea Compounds; Organophosphorus Compounds; Thymidine; Tumor Cells, Cultured | 1990 |
Effect of thymidine on uptake, DNA alkylation, and DNA repair in L1210 cells treated with 1,3-bis(2-chloroethyl)-1-nitrosourea or 3'-[3-(2-chloroethyl)-3-nitrosoureido]-3'-deoxythymidine.
Topics: Alkylation; Animals; Carmustine; Cell Line; Dideoxynucleosides; DNA; DNA Repair; Drug Synergism; Leukemia L1210; Mice; Nitrosourea Compounds; Thymidine | 1988 |
Pulmonary toxicity of cytostatic drugs: cell kinetics.
Topics: Animals; Autoradiography; Busulfan; Carmustine; Cell Division; Cyclophosphamide; DNA Replication; Kinetics; Lung; Male; Mice; Mice, Inbred BALB C; Oleic Acid; Oleic Acids; Thymidine; Tritium | 1987 |
Effects of sodium cyanate in mice bearing B16 melanoma.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carmustine; Cyanates; Eating; Female; Lomustine; Melanoma; Mice; Mice, Inbred C57BL; Thymidine | 1986 |
Enhancement of the anticancer activity of bis(2-chloroethyl)nitrosourea in mice by coadministration of 2'-deoxyuridine, 2'-deoxycytidine, or thymidine.
Topics: Animals; Carmustine; Deoxycytidine; Deoxyribonucleosides; Deoxyuridine; Drug Synergism; Leukemia L1210; Melanoma, Experimental; Mice; Ribonucleosides; Thymidine | 1987 |
Mitozolomide activity on human cancer cells in vitro.
Topics: Aged; Antineoplastic Agents; Carmustine; Cell Cycle; Cell Line; Dose-Response Relationship, Drug; Female; Flow Cytometry; Humans; Melanoma; Middle Aged; Mitosis; Nitrogen Mustard Compounds; Ovarian Neoplasms; Thymidine | 1986 |
Enhanced acute lung damage in mice following administration of 1,3-bis(2-chloroethyl)-1-nitrosourea.
Topics: Animals; Butylated Hydroxytoluene; Carmustine; DNA; Glutathione Reductase; Hydroxyproline; Lung; Male; Mice; Mice, Inbred BALB C; Rats; Rats, Inbred Strains; Thymidine | 1985 |
The sensitivity of cells in exponential and stationary phases of growth to bleomycin and to 1,3-bis(2-chloroethyl)-1-nitrosourea.
Topics: Animals; Bleomycin; Carmustine; Cell Line; Cells, Cultured; Culture Techniques; DNA; Dose-Response Relationship, Drug; Mice; Neoplasms, Experimental; Spleen; Thymidine; Time Factors; Tritium | 1973 |
In vitro methods to complement in vivo approaches utilizing combinations of chemotherapy and immunotherapy.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; Bleomycin; Carmustine; Cells, Cultured; Chickens; Clone Cells; Concanavalin A; Culture Techniques; Cytarabine; Cytological Techniques; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Humans; Immunity, Cellular; Immunotherapy; Lectins; Lipopolysaccharides; Lymphocytes; Melanoma; Mice; Mitosis; Neoplasms; Neoplasms, Experimental; Thymidine | 1974 |
Alterations induced by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in deoxyribonucleic acid synthesis in normal and tumorous tissues. Implications for optimal chemotherapy.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Carmustine; DNA; DNA, Neoplasm; Dose-Response Relationship, Drug; Female; Gastric Mucosa; Intestinal Mucosa; Leukemia L1210; Mice; Mice, Inbred Strains; Neoplasms; Nitrosourea Compounds; Thymidine; Time Factors; Tritium | 1974 |
Duration of inhibition of synthesis of DNA in tumors and host tissues after single doses of nitrosoureas.
Topics: Animals; Bone Marrow; Brain; Carmustine; Cricetinae; Cyclohexanes; Depression, Chemical; DNA, Neoplasm; Kidney; Liver; Lung; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasms, Experimental; Nitrosourea Compounds; Plasmacytoma; Spleen; Thymidine; Time Factors; Tritium | 1974 |
The effect of chemotherapeutic agents on the incorporation of DNA precursors by experimental brain tumors.
Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Bone Marrow; Brain; Brain Neoplasms; Carbon Isotopes; Carmustine; Cyclohexanes; Cytarabine; Deoxyuridine; Disease Models, Animal; DNA, Neoplasm; Dose-Response Relationship, Drug; Ependymoma; Glioma; Lymph Nodes; Male; Methotrexate; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; Nitrosourea Compounds; Thymidine; Tritium | 1972 |
Antitumour imidazotetrazines--IV. An investigation into the mechanism of antitumour activity of a novel and potent antitumour agent, mitozolomide (CCRG 81010, M & B 39565; NSC 353451).
Topics: Adenosine; Aminoimidazole Carboxamide; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Carmustine; Cells, Cultured; Chymotrypsin; DNA, Neoplasm; gamma-Glutamyltransferase; Glutathione Reductase; Imidazoles; Lymphoma; Mice; Nitrogen Mustard Compounds; Thymidine; Uridine | 1984 |
Functional and chemical markers of PCNU activity.
Topics: Animals; Antineoplastic Agents; Carmustine; DNA; Humans; Leukemia; Mice; Nitrosourea Compounds; Phenobarbital; Thymidine | 1983 |
Drug resistance in multiple myeloma associated with high in vitro incorporation of 3H-thymidine.
Topics: Carmustine; Cell Nucleus; Cell Transformation, Neoplastic; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Humans; Melphalan; Multiple Myeloma; Thymidine; Vincristine | 1981 |
Peritoneal exudate mononuclear phagocyte colony-forming cells: their proliferative state in vivo and sensitivity to cytotoxic agents.
Topics: Animals; Ascitic Fluid; Autoradiography; Carmustine; Cell Division; Colony-Forming Units Assay; Cyclophosphamide; Cytarabine; Female; Hematopoietic Stem Cells; Macrophages; Male; Mechlorethamine; Methotrexate; Mice; Mice, Inbred C3H; Thymidine; Tritium; Vinblastine | 1980 |
Similar toxic effect of 1,3-bis(2-chloroethyl)-1-nitrosourea on lymphocytes from human subjects differing in the expression of glutathione transferase M1-1.
Topics: Carmustine; Gene Expression; Glutathione Transferase; Humans; Lymphocytes; Phytohemagglutinins; Thymidine | 1994 |
Immunomodulation and enhancement of antitumor activity by co-administration of 1,3-bis(2-chloroethyl)-1-nitrosourea and thymidine.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents, Alkylating; Carmustine; Female; Hypersensitivity, Delayed; Killer Cells, Natural; Lymphocyte Activation; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Thymidine; Tumor Cells, Cultured | 1997 |
Synthesis and characterization of DNA containing an N1-2'-deoxyinosine-ethyl-N3-thymidine interstrand cross-link: a structural mimic of the cross-link formed by 1,3-bis-(2-chloroethyl)-1-nitrosourea.
Topics: Carcinogens; Carmustine; Chromatography, High Pressure Liquid; Circular Dichroism; Cross-Linking Reagents; DNA; DNA Repair; Indicators and Reagents; Inosine; Models, Molecular; Nucleic Acid Denaturation; Oligonucleotides; Thymidine; Ultraviolet Rays | 2008 |